March 15th 2021Justin Varholick, PhD
Recently, a team of scientists from Yale University and Sapparo Medical University in Japan treated spinal cord injury patients with their own bone marrow derived mesenchymal stem cells (MSCs), increasing their ability to walk and use their hands. Previous to the treatment, 13 patients had sustained falls or minor spinal trauma resulting in loss of motor function, coordination, sensory loss, as well as bowel and bladder dysfunction. After being bedridden for several weeks from an unexpected fall, the first patient was extremely thankful to be able to independently use a wheelchair and walk upright with a walker. Thanks to their own stem cells.
This published research was just a trial in safety and tolerability in humans. Meaning that it doesnt definitively demonstrate that the MSC treatment resulted in improved motor ability compared to no treatment or more conventional approaches (i.e. theres no proven efficacy). This is exactly what the team of scientists and physicians are planning to do next, now that they know it is safe. But how did we get here?
What is an MSC?
As you might have learned in your high school biology class, your body is always making new blood cells. So, if we lose blood from an injury or donate it, we can make more of it. The source of these new blood cells is the hematopoietic stem cell (HSC). HSCs are found in the bone marrow and are potent stem cells, able to make (or differentiate into) red blood cells, white blood cells, macrophages, and natural killer cells, to name a few. MSCs (used in the above study) are also found in bone marrow, and are thought to be important for creating a niche, or home, for those HSCs. But thats not all MSCs do. They are also important for repairing skeletal tissues like bone, cartilage, and the fat found in bone marrow. Whats more, is that research has found that these MSCs are pluripotent, able to differentiate into many different cell types. Not only can they become bone, cartilage, or fat cells; they can also differentiate into skin, trachea, cornea, liver, nerve, heart, and muscle cells.
Pluripotency makes MSCs a boon for regenerative medicine, which aims to replace traditional medical practices of repair with regeneration. For example, regenerative therapies could aim to fully regenerate new skin after traumatic burn injury without scarring (see the African spiny mouse), rather than replacing the area with a graft of the patients own skin.
Or, regenerate damaged spinal cord tissue without scarring (see zebrafish and axolotls), rather than just removing broken pieces, stabilizing the spine, or providing rehabilitative therapy. Current medical treatments cannot reverse damage to the spinal cord, but regenerative medicine makes this a possibility.
Regenerating spinal cord tissue after injury can seem fantastical since humans currently cannot regenerate complex tissues after traumatic injury (although they can regenerate a surprising array of simple tissues) However, transplanting MSCslike the treatment done by the Yale and Sapparo scientists and physicianshas demonstrated promise in animal research using chickens, mice, rats, rabbits, and dogs.
A Brief History on MSCs and #AnimalResearch
Early experiments (here) on chickens dating back to the late 1800s (#timescales) demonstrated that bone marrow itself can generate bone tissue within the muscle tissuewhere it does not belong. Such types of experiments continued into the late 1960s on rats, rabbits, and dogs (here) without clear understanding of which exact cells were responsible for the generation of new bone tissue. Around this time, a group of Russian scientists were able to determine that a minor subpopulation of the bone marrow was responsible for the previously observed bone growth, and could be manipulated to generate bone, cartilage, fat, and fibrous tissue in mice. Such experiments dubbed these stem cells as osteogenic stem cells (i.e. bone forming).
Although many recognized that these osteogenic stem cells were different from the HSCs making the blood, it wasnt until the early 1990s when Osiris Therapeutics out of Cleveland, Ohio established that osteogenic stem cells should be dubbed mesenchymal stem cells (MSCs) with a broader differentiation potential than just bone. This was also around the time that embryonic stem cells (ESCs) were gaining popularity (which you can read more about in a previous post). Ever since, scientists and the like have been experimenting with MSCs to generate new tissues with promising success.
For example, in a study (here) using rats, by the same team of scientists conducting the human clinical trial previously discussed, they found that their MSCs treatment also improved motor function, reduced leakage of the spinal cord at the site of injury, and resulted in greater repair of the injury itself. Thankfully this time, the scientists were able to compare the treatment to a control, providing robust evidence that the treatment was actually helpful compared to no treatment. This research paved the way for the clinical trial on humans.
Hopefully, we will hear sometime soon that the MSCs can indeed improve recovery after spinal cord injury. Until then, we will just have to continue doing animal research and continue to watch how the safety trials are going in Japan for other stem cell therapies treating heart attack or stroke.
Like Loading...
Related
Originally posted here:
One step closer to treating spinal cord injury with our own stem cells - Speaking of Research
- One year to test 200 Cordlife samples 'totally unjustified': Global cord blood banking experts - The Straits Times - April 15th, 2024
- Clinical trial: First cardiac bioimplants for treatment of myocardial infarction using umbilical cord stem cells - Medical Xpress - April 7th, 2024
- The umbilical cord: a rich and ethical stem cell source to advance ... - March 30th, 2024
- Story of discovery: getting a Notch up on cord blood cell ... - March 30th, 2024
- Cord Blood Transplants | Memorial Sloan Kettering Cancer Center - March 30th, 2024
- Therapeutic effect and study of human umbilical cord blood mononuclear cells in patients with ischaemic bowel ... - Nature.com - March 17th, 2024
- Global Cord Blood & Tissue Banking Industry Report 2024: The Vast Majority of the Global Cord Blood Market is Now ... - PR Newswire - March 15th, 2024
- Improving Transplant Outcomes and Cell Therapy Approaches - RegMedNet - March 9th, 2024
- The inhibition of ADAM17 in cord blood stem cell-derived CD16+ NK cells to enhance their cytotoxicity against acute ... - ScienceDirect.com - March 1st, 2024
- Beating Blood Cancer through Recycling - a Community crowdfunding project in Liverpool by Kate Williams - Crowdfunder UK - February 24th, 2024
- Cord Blood Registry (CBR ) by CooperSurgical and Fulgent Genetics Launch Innovative Genetic Testing - Investing.com Canada - February 9th, 2024
- Young cancer patient with 'no hope' of recovery saved by baby's umbilical cord - Study Finds - February 9th, 2024
- Global Cord Blood & Tissue Banking Industry Report 2024 - The Vast Majority of the Global Cord Blood Market is Now ... - ACROFAN - January 26th, 2024
- Finding the optimal combination of anticancer drug administration for the conditioning of cord blood transplantation - Medical Xpress - January 26th, 2024
- Cord Blood Banking Market Sales and Revenue Report 2023-2032 - WhaTech Technology and Markets News - January 26th, 2024
- Global Cord Blood & Tissue Banking Industry Report 2024 - The Vast Majority of the Global Cord Blood Market is Now ... - ACROFAN USA - January 24th, 2024
- Global Biobanking Market Size To Exceed USD 97.5 Billion By 2032 | CAGR of 5.8% - GlobeNewswire - January 24th, 2024
- The use of cryopreservation in life saving research - The Manufacturer - January 24th, 2024
- CD19-targeted CAR NK cell therapy achieves promising one-year results in patients with B-cell malignancies - Medical Xpress - January 18th, 2024
- Cord blood banking comes at a high cost to babies - STAT - STAT - January 18th, 2024
- Global Cord Blood and Tissue Banking Industry Gains Traction Amidst Surging M&A Activity and Technological Advances - PR Newswire - January 16th, 2024
- Donating Bone Marrow and Stem Cells: The Process and What To Expect - On Cancer - Memorial Sloan Kettering - January 11th, 2024
- Ask the doctors: Research being conducted on using stem cells to treat diabetes - The Spokesman Review - January 4th, 2024
- askST: Can cord blood units be transferred from one bank to another? - The Straits Times - December 27th, 2023
- Timeline: Cordlife's mishandling of cord blood units in Singapore - CNA - December 15th, 2023
- Next-Level Evolution: Enhancing the Human Body With Anthrobots ... - Securities.io - December 5th, 2023
- Fred Hutch at ASH: Gene therapies for sickle cell, how to improve ... - Fred Hutchinson Cancer Center - December 5th, 2023
- Enhancing the immunosuppressive properties of human umbilical ... - Phys.org - December 1st, 2023
- Global Status and Trends for Thromboangiitis Obliterans | JPR - Dove Medical Press - December 1st, 2023
- Early Stage Cell Therapy Trial Shows Promise in Treating Progressive Multiple Sclerosis - University of Colorado Anschutz Medical Campus - December 1st, 2023
- Global Medical Specialty Bag Market is Expected to Reach US$ 9.4 Billion by 2034, Rising at a Steady 4.7% CAGR | Future Market Insights, Inc. - Yahoo... - November 29th, 2023
- Repeated concussions can alter heart activity and impact the heart ... - Philippine Canadian Inquirer - November 29th, 2023
- Vita 34 increases revenue and earnings in Q3 2023 and further ... - PharmiWeb.com - November 27th, 2023
- Vita 34 increases revenue and earnings in Q3 2023 and further ... - Marketscreener.com - November 25th, 2023
- FY 2021 VA-Funded Projects - VA's Office of Research and Development - November 25th, 2023
- New study aims to expand access to stem cell transplant using ... - Healio - November 23rd, 2023
- Impact of GVHD Prophylaxis on CMV Reactivation and Disease ... - Cancer Network - November 23rd, 2023
- The Top 25 Women Leaders in Biotechnology of 2023 - The Healthcare Technology Report. - November 21st, 2023
- First Edition: November 20, 2023 - KFF Health News - November 21st, 2023
- An essential guide to the building blocks of life - Gates Notes - November 21st, 2023
- A Simple Way to Save Premature Babies - The New York Times - November 19th, 2023
- Perspectives of current understanding and therapeutics of Diamond ... - Nature.com - November 17th, 2023
- Brain Organoids: Should They Be Considered People? - BBVA OpenMind - November 17th, 2023
- Understanding the cause of childhood Alzheimer's - ASBMB Today - November 17th, 2023
- Peripheral nerve regeneration through nanofiber scaffolds | IJN - Dove Medical Press - November 15th, 2023
- Are STEM CELL EXOSOMES the secret to a 'snatched' jawline? Discover the products that influencers are claiming - Daily Mail - November 13th, 2023
- CAR-NK: The next generation in hematological malignancy treatment - News-Medical.Net - November 13th, 2023
- Regenerative Medicine | Top Regenerative Medicine Solution ... - Healthcare Tech Outlook - November 13th, 2023
- Stem cell therapy, emerging solution to slow down ageing - Punch Newspapers - November 13th, 2023
- Improving Cord Blood Transplantation Outcomes for Adults With ... - On Cancer - Memorial Sloan Kettering - November 11th, 2023
- 8 Ways To Save Lives With Canadian Blood Services & You Can ... - Narcity Canada - November 11th, 2023
- Internal investigation by Vita 34 AG reveals irregularities related to a ... - Marketscreener.com - November 11th, 2023
- 'We worried the worst would happen' - Yorkshire Children's Trust ... - The Yorkshire Post - November 11th, 2023
- Minor GPI(-) granulocyte populations in aplastic anemia and healthy ... - Nature.com - November 9th, 2023
- Repeated treatment with ProTrans is immunologically safe ... - Marketscreener.com - November 7th, 2023
- Affimed Announces Oral Presentation of Phase 1/2 Data from AFM13 in Combination with Allogeneic NK Cells - Benzinga - November 7th, 2023
- Health Canada issues warning on cord blood stored in Edmonton - CBC News - November 3rd, 2023
- Affimed Announces Oral Presentation of Phase 1/2 Data from AFM13 in Combination with Allogeneic NK Cells at the 2023 ASH Annual Meeting - Yahoo... - November 3rd, 2023
- Dynamic Stem Cell Therapy Uncovers Research in Advance ... - InvestorsObserver - November 3rd, 2023
- Go with the flow and achieve hearing restoration - Drug Discovery News - November 3rd, 2023
- Cell Therapy Market to Witness Exponential Growth by 2031 ... - Argyle Report - November 1st, 2023
- Cross-talk between Myeloid and B Cells Shapes the Distinct ... - Cancer Discovery - November 1st, 2023
- Comparison of effects of HucMSCs, exosomes, and conditioned ... - Nature.com - October 28th, 2023
- The structural and functional complexity of the integrative ... - Science - October 28th, 2023
- Global Primary Cells Market to Witness Growth at 11.41% CAGR to ... - GlobeNewswire - October 26th, 2023
- Hma-Qubec celebrates 25 years of giving life in anniversary ad - - The Message - October 26th, 2023
- Improvement of thermal-stability of chondroitinase ABCI immobilized ... - Nature.com - October 26th, 2023
- Sydney Couple Overcomes Sperm Antibody Issue to Welcome Baby - OPP.Today - October 24th, 2023
- New Research Reveals Surprising Issue with Sperm and Fertility - CityLife - October 24th, 2023
- Biobanking Market to Observe Prominent CAGR of 6.10% by 2029 ... - PharmiWeb.com - October 21st, 2023
- TV shows like BBC's Call The Midwife and C4's One Born Every Minute 'are inaccurately depicting childbirth' an - Daily Mail - October 19th, 2023
- Advances in medical and technological research and SCI - Clyde & Co - October 18th, 2023
- Prognostic Value of Hematogones in Patients With Hematopoietic ... - Cureus - October 18th, 2023
- Stem-Cell Therapy: Filling Gaps in Oro-Maxillofacial Region - Cureus - October 18th, 2023
- The neonatal southern white rhinoceros ovary contains oogonia in ... - Nature.com - October 18th, 2023
- OMG: Sperm injury led to rare baby struggle - news.com.au - October 18th, 2023
- Experts Explain how MS Impacts the Eyes and Eye Health - Health Central - October 18th, 2023
- Newly identified stem cells can lure breast cancer to the spine - Science News Magazine - October 15th, 2023
- Cases of HIV cure | aidsmap - aidsmap - October 15th, 2023
- HokUS-10 scoring system predicts the treatment outcome for ... - Nature.com - October 13th, 2023
Recent Comments